The National Emerging Infectious Diseases Laboratories (NEIDL) is a state-of-the-art research facility located in Boston, Massachusetts, and operated by Boston University. NEIDL is designed to provide a safe and controlled environment for conducting research on infectious diseases that are of public health concern.
The NEIDL facility is equipped with advanced biosafety level (BSL) laboratories, capable of handling highly infectious agents such as Ebola, tuberculosis, and other emerging viruses. These laboratories are specifically designed to prevent the accidental release of pathogens and to protect researchers and the surrounding community from potential exposure. NEIDL also includes dedicated animal research facilities to study infectious diseases in animal models.
The goal of NEIDL is twofold: to enhance our understanding of emerging and re-emerging infectious diseases and to develop effective countermeasures against them. Scientists at NEIDL study the mechanisms of infection, host-pathogen interactions, and the development of vaccines and therapeutics. The research conducted at NEIDL is crucial for addressing public health challenges, such as pandemics and bioterrorism threats.
In addition to its research activities, NEIDL also prioritizes biosafety and training programs to ensure the safe handling and containment of infectious agents. This includes rigorous safety protocols, regular risk assessments, and ongoing collaboration with local, state, and federal agencies responsible for public health and safety.
Overall, NEIDL serves as a vital resource for advancing our understanding of infectious diseases, protecting public health, and developing strategies to combat emerging threats in a safe and controlled environment.
